Scottsdale, AZ — June 3, 2010 — Cayenne Medical, Inc., a privately held sports medicine device company, announced the appointment of Michael T. Gillem as Vice President of Sales, effective June 1, 2010. Gillem, who will be responsible for the direction and management of all sales activities for the Company’s AperFix® and CrossFixTM systems, brings more than 18 years of medical device industry sales and sales management experience. Read more — download the full press release.
Scottsdale, AZ — April 26, 2010 — Cayenne Medical, Inc. (Cayenne), a privately held sports medicine device company, announced the appointment of Randy Buness as Chief Financial Officer, effective April 26, 2010. Mr. Buness, who will be responsible for all financial operations of the Company, brings more than 25 years of financial experience and results-oriented leadership.
“We are very pleased to welcome Randy as Cayenne’s Chief Financial Officer,” said James W. Hart, President and CEO of Cayenne Medical. “He is a talented finance professional with an impressive track record, and I am confident that his leadership will be a great addition to our management team.” Read more — download the full press release.
SCOTTSDALE, Ariz., April 8 /PRNewswire/—Cayenne Medical, Inc. (Cayenne), a privately held sports medicine device company, announced that a new independent clinical study published in the February 2010 issue of Orthopedics reports Cayenne’s AperFix® System provides a safe, efficient and secure means of arthroscopic reconstruction of the posterior cruciate ligament (PCL) due to traumatic injury. Read more — download the full press release.
SCOTTSDALE, AZ – July 15, 2009 – Cayenne Medical, Inc., a privately held sports medicine company based in Scottsdale, announced the commercial launch of its CrossFix™ System for the repair of meniscal tears at the American Orthopaedic Society for Sports Medicine (AOSSM) annual meeting in Keystone, Colorado last week. The CrossFix™ system offers surgeons the benefits of both open suturing and arthroscopic meniscal repair. The technology replicates results from “gold standard” open suturing techniques but through a faster and less invasive all-inside method. Unlike traditional all-inside meniscal repair devices, the CrossFix™ system leaves no plastic implants behind, thereby reducing risk of injury over time. Read more — download the full press release.
BOSTON, MA – March 18, 2009 – Cayenne Medical, Inc., a privately held sports medicine company based in Scottsdale, announced today that a new Harvard biomechanical study published in the American Journal of Sports Medicine (AJSM) found that Cayenne’s AperFix® System and “Single Tunnel, Double Bundle™” ACL reconstruction technique better resembles the natural, intact ACL when compared to the more common, “Single-Bundle” technique. Read more — download the full press release.
SCOTTSDALE, AZ - March 6, 2008 - Cayenne Medical, Inc., a privately held sports medicine company based in Scottsdale, Arizona announced today that it has closed a $15 million Series C financing led by Investor Growth Capital (“IGC”). Other participating investors include SplitRock Partners, MB Venture Partners and a group of accredited private individuals. Stephen M. Campe, Managing Director of IGC, has joined Cayenne’s Board in connection with the financing. This financing round brings Cayenne’s total private equity investment to $32 million. Read more — download the full press release.
SCOTTSDALE, AZ - February 26, 2008 - Cayenne Medical, Inc., a privately held sports medicine company based in Scottsdale, announced today that it has received market clearance from the U.S. Food and Drug Administration (FDA) for its iFix™ Interference Screw System for use in bone-tendon-bone ACL reconstruction procedures. Read more — download the full press release.